rs12232780
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003072.5(SMARCA4):c.2617-321G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.276 in 440,446 control chromosomes in the GnomAD database, including 18,525 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.24 ( 4941 hom., cov: 33)
Exomes 𝑓: 0.30 ( 13584 hom. )
Consequence
SMARCA4
NM_003072.5 intron
NM_003072.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.325
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 19-11021404-G-A is Benign according to our data. Variant chr19-11021404-G-A is described in ClinVar as [Benign]. Clinvar id is 1249450.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.331 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.2617-321G>A | intron_variant | Intron 18 of 35 | NM_001387283.1 | ENSP00000495368.1 | ||||
SMARCA4 | ENST00000344626.10 | c.2617-321G>A | intron_variant | Intron 18 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
SMARCA4 | ENST00000643549.1 | c.2617-321G>A | intron_variant | Intron 18 of 34 | ENSP00000493975.1 | |||||
SMARCA4 | ENST00000541122.6 | c.2617-321G>A | intron_variant | Intron 19 of 34 | 5 | ENSP00000445036.2 | ||||
SMARCA4 | ENST00000643296.1 | c.2617-321G>A | intron_variant | Intron 18 of 33 | ENSP00000496635.1 | |||||
SMARCA4 | ENST00000644737.1 | c.2617-321G>A | intron_variant | Intron 18 of 33 | ENSP00000495548.1 | |||||
SMARCA4 | ENST00000589677.5 | c.2617-321G>A | intron_variant | Intron 19 of 34 | 5 | ENSP00000464778.1 | ||||
SMARCA4 | ENST00000643995.1 | c.2029-321G>A | intron_variant | Intron 15 of 31 | ENSP00000496004.1 | |||||
SMARCA4 | ENST00000644963.1 | c.1261-321G>A | intron_variant | Intron 11 of 27 | ENSP00000495599.1 | |||||
SMARCA4 | ENST00000644065.1 | c.1342-321G>A | intron_variant | Intron 11 of 26 | ENSP00000493615.1 | |||||
SMARCA4 | ENST00000642350.1 | c.1102-321G>A | intron_variant | Intron 10 of 26 | ENSP00000495355.1 | |||||
SMARCA4 | ENST00000643857.1 | c.970-321G>A | intron_variant | Intron 9 of 24 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes AF: 0.237 AC: 36013AN: 152066Hom.: 4943 Cov.: 33
GnomAD3 genomes
AF:
AC:
36013
AN:
152066
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.297 AC: 85670AN: 288262Hom.: 13584 Cov.: 0 AF XY: 0.305 AC XY: 46840AN XY: 153512
GnomAD4 exome
AF:
AC:
85670
AN:
288262
Hom.:
Cov.:
0
AF XY:
AC XY:
46840
AN XY:
153512
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.237 AC: 36013AN: 152184Hom.: 4941 Cov.: 33 AF XY: 0.241 AC XY: 17900AN XY: 74402
GnomAD4 genome
AF:
AC:
36013
AN:
152184
Hom.:
Cov.:
33
AF XY:
AC XY:
17900
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
928
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Jul 27, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at